34 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
ADGRF4 Adhesion G protein-coupled receptor F4
Mitochondria Pancreatic cancer: 5.52e-4 Group enriched 7 esophagus: 12.1 skin: 45.9
ALOX12 Arachidonate 12-lipoxygenase
Nuclear speckles Group enriched 5 esophagus: 50.5 skin: 26.0
ANXA8L1 Annexin A8-like 1
Nucleoplasm Group enriched 7 esophagus: 200.1 skin: 461.5
BNIPL BCL2/adenovirus E1B 19kD interacting protein like
Thyroid cancer: 4.32e-4 Endometrial cancer: 6.50e-4 Group enriched 7 esophagus: 89.3 skin: 227.3
CD1A CD1a molecule
Cervical cancer: 6.37e-4 Group enriched 6 esophagus: 9.5 skin: 27.1
DSC3 Desmocollin 3
Plasma membrane Urothelial cancer: 1.04e-5 Group enriched 11 esophagus: 119.5 skin: 455.7
DSP Desmoplakin
Cell Junctions Renal cancer: 1.53e-9 Urothelial cancer: 1.82e-4 Group enriched 8 esophagus: 346.9 skin: 1019.0
ENDOU Endonuclease, polyU-specific
Head and neck cancer: 6.29e-4 Group enriched 6 esophagus: 70.6 skin: 24.9
EVPL Envoplakin
Intermediate filaments Group enriched 9 esophagus: 77.8 skin: 111.3
FAM83C Family with sequence similarity 83, member C N/A
Group enriched 15 esophagus: 19.9 skin: 43.2
GJB5 Gap junction protein, beta 5, 31.1kDa N/A
Pancreatic cancer: 1.54e-4 Group enriched 6 esophagus: 56.7 skin: 77.6
IL20RB Interleukin 20 receptor beta
Renal cancer: 0.00e+0 Pancreatic cancer: 1.44e-4 Group enriched 9 esophagus: 56.8 skin: 166.0
IVL Involucrin
Nuclear bodies Group enriched 6 esophagus: 309.5 skin: 131.5
JUP Junction plakoglobin
Vesicles Renal cancer: 2.06e-10 Group enriched 6 esophagus: 493.6 skin: 787.3
KLK7 Kallikrein-related peptidase 7
Plasma membrane Endometrial cancer: 8.06e-5 Pancreatic cancer: 1.16e-4 Group enriched 5 esophagus: 68.9 skin: 220.0
KRT3 Keratin 3, type II
Group enriched 5 esophagus: 1.3 skin: 1.8
KRT31 Keratin 31, type I
Group enriched 6 esophagus: 4.7 skin: 14.4
KRT32 Keratin 32, type I
Group enriched 13 esophagus: 7.5 skin: 2.4
KRT5 Keratin 5, type II
Breast cancer: 1.27e-4 Group enriched 9 esophagus: 3269.5 skin: 6006.7
LY6D Lymphocyte antigen 6 complex, locus D
Pancreatic cancer: 1.94e-6 Renal cancer: 1.20e-4 Group enriched 11 esophagus: 634.4 skin: 717.6
LYPD3 LY6/PLAUR domain containing 3
Endoplasmic reticulum Lung cancer: 7.86e-5 Group enriched 5 esophagus: 676.5 skin: 594.5
NMU Neuromedin U N/A
Renal cancer: 4.07e-10 Endometrial cancer: 2.60e-5 Group enriched 6 esophagus: 35.0 skin: 45.4
PERP PERP, TP53 apoptosis effector
Pancreatic cancer: 1.05e-5 Lung cancer: 3.73e-4 Breast cancer: 5.46e-4 Group enriched 6 esophagus: 574.1 skin: 1238.6
PGLYRP3 Peptidoglycan recognition protein 3 N/A
Group enriched 9 esophagus: 43.2 skin: 87.7
PGLYRP4 Peptidoglycan recognition protein 4
Vesicles Group enriched 5 esophagus: 5.8 skin: 18.2
PKP1 Plakophilin 1
Nucleoplasm Group enriched 11 esophagus: 282.7 skin: 823.7
PLEKHN1 Pleckstrin homology domain containing, family N member 1
Nuclear speckles Renal cancer: 4.97e-5 Group enriched 11 esophagus: 17.0 skin: 44.0
PPL Periplakin
Nucleoplasm Ovarian cancer: 2.76e-4 Group enriched 7 esophagus: 560.8 skin: 149.9
SBSN Suprabasin
Vesicles Group enriched 12 esophagus: 1059.9 skin: 2694.5
SERPINB5 Serpin peptidase inhibitor, clade B (ovalbumin), member 5
Vesicles Pancreatic cancer: 5.71e-6 Lung cancer: 1.54e-4 Group enriched 6 esophagus: 221.1 skin: 262.5
SFN Stratifin
Cytosol Renal cancer: 7.45e-6 Liver cancer: 5.68e-5 Endometrial cancer: 1.92e-4 Pancreatic cancer: 6.01e-4 Group enriched 8 esophagus: 1094.4 skin: 1158.9
SLURP1 Secreted LY6/PLAUR domain containing 1
Group enriched 32 esophagus: 743.9 skin: 296.7
TGM5 Transglutaminase 5
Group enriched 7 esophagus: 8.4 skin: 22.5
TRIM29 Tripartite motif containing 29
Nucleoplasm Endometrial cancer: 2.88e-4 Pancreatic cancer: 4.46e-4 Stomach cancer: 4.93e-4 Group enriched 6 esophagus: 401.8 skin: 456.6
Page
